Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 40kWORD 9k
23 March 2020
Question for written answer
to the Commission
Rule 138
Robert Hajšel
 Answer in writing 
 Subject: EU measures to combat the spread of SARS-COV2

The EU has already adopted a number of measures to combat the spread of SARS-COV2, although the main competences in the area of public health protection lie with the Member States. Many of these measures are very important, but their impact is not visible to our citizens. Meanwhile, they are currently receiving reports about concrete assistance being provided by Russia and China. Our citizens expected the EU to respond faster.

1. When thousands of Europeans are dying, providing an effective drug is certainly the best thing to do. No drugs have yet been certified for this disease, but several existing ones have proven to be at least partially effective. How does the Commission plan to effectively coordinate the research being carried out by individual companies and countries and, in particular, research aimed at providing an effective antiviral drug that could be administered to thousands of at-risk patients across the EU?

2. What specific steps has the Commission taken to this end in connection with governments and companies in countries such as Japan, China, Russia, and the USA, which have experience in administering such drugs?

3. What steps is the Commission taking or planning to take in order to ensure that the most vital medical supplies – such as ventilators, respirators, protective suits (not only from the EU but from around the world) – reach the people most affected when they need them?

Original language of question: SK
Last updated: 7 April 2020Legal notice - Privacy policy